Medical reduction of stone risk in a network of treatment centers compared to a research clinic

Journal of Urology

Volumn 160, Issue 5, 1998, Pages 1629-1634

  Lingeman, J ^{a,b,c,d,e,f,g}   Mardis, H ^{a,b,c,d,e,f,g}   Kahnoski, R ^{a,b,c,d,e,f,g}   Goldfarb, D S ^{a,b,c,d,e,f,g}   Lacy, S ^{a,b,c,d,e,f,g}   Grasso, M ^{a,b,c,d,e,f,g}   Scheinman, S J ^{a,b,c,d,e,f,g}   Parks, J H ^{a,b,c,d,e,f,g}   Asplin, J R ^{a,b,c,d,e,f,g}   Coe, F L ^{a,b,c,d,e,f,g}  

^a UNIVERSITY OF CHICAGO   (United States)

^b METHODIST HOSPITAL   (United States)

^c Michigan Medical   (United States)

^d The Urology Center PC   (United States)

^e Urology P C   (United States)

^f State University of New York Upstate Medical University: College of Medicine   (United States)

^g NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Kidney calculi; Treatment outcome; Urine

Indexed keywords

CALCIUM OXALATE; CALCIUM PHOSPHATE; URIC ACID;

ADULT; ARTICLE; CLINICAL RESEARCH; COMPARATIVE STUDY; COMPUTER PROGRAM; FEMALE; HUMAN; LABORATORY; MALE; MULTICENTER STUDY; NEPHROLITHIASIS; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0345411427     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62365-6     Document Type: Article

References (32)

1. Parks, J. H. and Coe, F. L.: An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney Int., 45: 1722, 1994.
2. Ettinger, B., Citron, J. T., Livermore, B. and Dolman, L. I.: Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J. Urol., 139: 679, 1988.
3. Ettinger, B., Tang, A., Citron, J. T., Livermore, B. and Williams, T.: Randomized trial of allopurinol in the prevention of calcium oxalate calculi. New Engl. J. Med., 315: 1386, 1986.
4. Pak, C. Y. C., Fuller, C., Sakhaee, K., Preminger, G. M. and Britton, F.: Long-term treatment of calcium nephrolithiasis with potassium citrate. J. Urol., 134: 11, 1985.
5. Barcelo, P., Wuhl, O., Servitge, E., Rousaud, A. and Pak, C. Y. C.: Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J. Urol., 150: 1761, 1993.
6. Coe, F. L., Parks, J. H. and Asplin, J. R.: The pathogenesis and treatment of kidney stones. New Engl. J. Med., 327: 1141, 1992.
7. Smith, L. H.: The medical aspects of urolithiasis: an overview. J. Urol., 141: 707, 1989.
8. Asplin, J. R., Parks, J. H. and Coe, F. L.: Dependence of upper limit of metastability on supersaturation in nephrolithiasis. Kidney Int., 52: 1602, 1997.
9. Coe, F. L., Favus, M. J., Pak, C. Y. C., Parks, J. H. and Preminger, G. M.: Kidney Stones: Medical and Surgical Management. Philadelphia: Lippincott-Raven Publishers, 1996.
10. Asplin, J. R., Favus, M. J. and Coe, F. L.: Nephrolithias. In: The Kidney, 5th ed. Philadelphia: W. B. Saunders Co., pp. 1893-1935, 1996.
11. Coe, F. L. and Favus, M. J.: Disorders of Bone and Mineral Metabolism. New York: Raven Press, 1992.
12. Favus, M. J., Berelowitz, M. and Coe, F. L.: Effects of somatostatin on intestinal calcium transport in the rat. Amer. J. Physiol. 241: G215, 1981.
13. Consensus conference. Prevention and treatment of kidney stones. J.A.M.A., 260: 977, 1988.
14. Parks, J. H. and Coe, F. L.: The financial effects of kidney stone prevention. Kidney Int., 50: 1706, 1996.
15. Coe, F. L. and Parks, J. H.: Clinical approach. In: Nephrolithiasis: Pathogenesis and Treatment, 2nd ed. Chicago: Year Book Medical Publishers, 1988.
16. Parks, J. H., Coward, M. and Coe, F. L.: Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int., 51: 894, 1997.
17. Asplin, J. R., Parks, J., Lingeman, J., Kahnowski, R., Mardis, H., Lacey, S., Goldfarb, D., Grasso, M. and Coe, F.: Supersaturation and stone composition in a network of dispersed treatment sites. J. Urol., 159: 1821, 1998.
18. Werness, P. G., Brown, C. M., Smith, L. H. and Finlayson, B.: EQUIL2: a basic computer program for the calculation of urinary saturation. J. Urol., 134: 1242, 1985.
19. Strauss, A. L., Coe, F. L., Deutsch, L. and Parks, J. H.: Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Amer. J. Med., 72: 17, 1982.
20. Parks, J. H., Coe, F. L. and Strauss, A. L.: Calcium nephrolithiasis and medullary sponge kidney in women. New Engl. J. Med., 306: 1088, 1982.
21. Herring, L. C.: Observations on the analysis of ten thousand urinary calculi. J. Urol., 88: 545, 1962.
22. Coe, F. L. and Parks, J. H.: New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. J. Bone Min. Res., 12: 522, 1997.
23. Coe, F. L.: Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann. Intern. Med., 87: 404, 1977.
24. Coe, F. L., Parks, J. H., Bushinsky, D. A., Langman, C. B. and Favus, M. J.: Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int., 33: 1140, 1988.
25. Kok, D. J., Iestra, J. A., Doorenbos, C. J. and Papapoulos, S. E.: The effects of dietary excesses in animal protein and in sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy men. J. Clin. Endocr. Metab., 71: 861, 1990.
26. Pak, C. Y. C., Sakhaee, K. and Fuller, C.: Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int., 30: 422, 1986.
27. Coe, F. L., Moran, E. and Kavalich, A. G.: The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J. Chronic Dis., 29: 793, 1976.
28. Coe, F. L. and Raisen, L.: Allopurinol treatment of uric-acid disorders in calcium-stone formers. Lancet, 1: 129, 1973.
29. Pak, C. Y. C., Sakhaee, K., Crowther, C. and Brinkley, L.: Evidence justifying a high fluid intake in treatment of nephrolithiasis. Ann. Intern. Med., 93: 36, 1980.
30. Curhan, G. C., Willett, W. C., Rimm, E. B. and Stampfer, M. J.: Family history and risk of kidney stones. J. Amer. Soc. Nephrol., 8: 1568, 1997.
31. Tiselius, H. G.: A simplified estimate of the ion-activity product of calcium phosphate in urine. Eur. Urol., 10: 191, 1984.
32. Thun, M. J. and Schober, S.: Urolithiasis in Tennessee: an occupational window into a regional problem. Amer. J. Public Health, 81: 587, 1991.